Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Aramark (ARMK.N)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (US$)	Price Target (US$)	Rating
2022-02-11	36.08	-	No Rating
2023-05-31	39.48	42.00	Neutral
2023-08-09	41.42	43.00	Neutral
2023-08-22	37.09	43.00	Buy
2023-10-04	24.85	29.00	Buy
2023-11-14	26.19	31.00	Buy
2024-01-03	27.68	32.00	Buy
2024-02-06	29.31	35.00	Buy
2024-06-21	33.91	40.00	Buy
2024-10-08	37.60	44.00	Buy
2024-11-11	38.68	46.00	Buy
2025-02-04	37.66	45.00	Buy
2025-04-11	33.13	40.00	Buy
2025-05-06	37.64	44.00	Buy

Disclosures

UBS Securities LLC makes a market in the securities and/or ADRs of this company.
UBS holds a long or short position of 0.5% or more of the listed shares of this company.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.